The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


AmBisome Liposomal Amphotericin B 50 mg Powder for Concentrate for Dispersion for Infusion



Gilead Sciences Ireland UCPA2322/001/001

Main Information

Trade NameAmBisome Liposomal Amphotericin B 50 mg Powder for Concentrate for Dispersion for Infusion
Active SubstancesAmphotericin b
Dosage FormConcentrate for solution for infusion
Licence HolderGilead Sciences Ireland UC
Licence NumberPA2322/001/001

Group Information

ATC CodeJ02AA Antibiotics
J02AA01 amphotericin B

Status

License statusAuthorised
Licence Issued13/12/1990
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back